KZNâs updated plans for vaccine roll-out
By Thobeka Ngema, Zainul Dawood
2h ago
Share
DURBAN - THE KwaZulu-Natal Department of Health plans to have an electronic and manual method of registering to be vaccinated, as well as measures to reach and vaccinate those living in rural areas.
Head of department Dr Sandile Tshabalala said they have been ready for the Phase 2 roll-out for a long time.
âWhatâs important is that we had planned to finish our Phase 1 at the latest on May 15, and after that we will start Phase 2, now that Minister Dr Zweli Mkhize announced that those outside health (those aged 60 and over only) can register on the website,â said Tshabalala.
J&J jabs expected to resume this week Claire Keeton > By Claire Keeton - 19 April 2021 - 10:34 The pause in the rollout of Johnson & Johnson s Covid-19 vaccine to investigate a very rare blood clotting disorder is likely to be lifted soon. File photo. Image: Dado Ruvic/Reuters
Prof Glenda Gray, co-principal investigator of the Sisonke implementation study, which is providing health-care workers with Covid-19 J&J vaccines, said on Monday morning the suspension of the inoculations is expected to be lifted soon.
The vaccinations were paused by the SA Health Products Regulatory Authority (Sahpra) on Tuesday night last week, the same day the US Food and Drug Administration paused its J&J rollout because of extremely rare and severe blood clots detected in six out of 6.8 million Americans vaccinated.
Mkhize optimistic Covid-19 population immunity will be reached as planned iol.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iol.co.za Daily Mail and Mail on Sunday newspapers.
J&J jabs expected to resume this week By Claire Keeton - 19 April 2021 The pause in the rollout of Johnson & Johnson s Covid-19 vaccine to investigate a very rare blood clotting disorder is likely to be lifted soon. File photo. Image: Dado Ruvic/Reuters
Prof Glenda Gray, co-principal investigator of the Sisonke implementation study, which is providing health-care workers with Covid-19 J&J vaccines, said on Monday morning the suspension of the inoculations is expected to be lifted soon.
The vaccinations were paused by the SA Health Products Regulatory Authority (Sahpra) on Tuesday night last week, the same day the US Food and Drug Administration paused its J&J rollout because of extremely rare and severe blood clots detected in six out of 6.8 million Americans vaccinated.
SAHPRA lifts pause on J&J vaccine with conditions
Search Polity
Note: Search is limited to the most recent 250 articles. To access earlier articles, click Advanced Search and set an earlier date range.
To search for a term containing the & symbol, click Advanced Search and use the search headings and/or in first paragraph options.
With.
Clear Search
Sponsored by
Sponsored by
The South African Health Products Regulatory Authority (SAHPRA) has recommended that the pause of the Sisonke vaccine trial study using the Johnson & Johnson Covid-19 vaccine be lifted, provided that specific conditions are met.
The US, South Africa and the European Union temporarily stopped the rollout of the Johnson & Johnson jab, after six cases of rare blood clotting were reported in the US.